AtomVie Global Radiopharma has signed a lease agreement with Panattoni Development Company in Hamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated to high-volume clinical and commercial GMP manufacturing and worldwide distribution of radiotherapeutics, an innovative, high-growth class of drugs for the treatment of cancer patients.

Currently located on the McMaster University campus, AtomVie operates a contract development and manufacturing organisation (CDMO) facility that is home to more than 10 international radiopharmaceutical GMP manufacturing programmes. The new facility of 64,000 sq ft, expected to be commissioned in 2024, will increase production capacity more than 10 times, allowing the expansion of its clinical and commercial operations to meet the needs of the rapidly expanding radiopharmaceutical market.

Hallmarks of the new facility include cleanrooms and laboratories to sustain over 18 production lines and space for dedicated, high-volume commercial manufacturing. The facility is located in the proximity of the Toronto Pearson International Airport, the John C Munro Hamilton International Airport and the US border